Zhongqiang Lin

Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis

Xiaoxi Liu, Qian Ma, Qiu Li et al. · Clinical Immunology · 2020 · 40 citations

Influence of Drug Properties and Formulation on In Vitro Drug Release and Biowaiver Regulation of Oral Extended Release Dosage Forms

Zhongqiang Lin, Deliang Zhou, Stephen W. Hoag et al. · The AAPS Journal · 2016 · 35 citations · Full text

Vitro Drug Release, Biowaiver Regulation, Medicine +6

Hospital and healthcare insurance system record–based epidemiological study of myasthenia gravis in southern and northern China

Wei Fang, Yan Li, Rong Mo et al. · Neurological Sciences · 2020 · 25 citations

Healthcare Insurance System, Clinical Epidemiology, Common Diseases +4

Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients

Qian Ma, Hao Ran, Yingkai Li et al. · Clinical Immunology · 2020 · 22 citations

Inflammation, Autoimmune Disease, Disease Severity +10

Leflunomide ameliorates experimental autoimmune myasthenia gravis by regulating humoral and cellular immune responses

Huan Huang, Hao Ran, Xiaoxi Liu et al. · International Immunopharmacology · 2021 · 17 citations

Inflammation, Autoimmune Disease, Immunology +10